1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cardiac Rhythm Management Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cardiac Rhythm Management Devices Market, China
3.1 Cardiac Rhythm Management Devices Market, China, Revenue ($m), 2018-2033
3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), by Segment, 2018-2033
3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), by Segment, 2018-2033
3.1.3 Pacemakers Market, China, Revenue ($m), by Segment, 2018-2033
3.2 Cardiac Rhythm Management Devices Market, China, Volume (Units), 2018-2033
3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), by Segment, 2018-2033
3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), by Segment, 2018-2033
3.2.3 Pacemakers Market, China, Volume (Units), by Segment, 2018-2033
3.3 Cardiac Rhythm Management Devices Market, China, Average Price ($), 2018-2033
3.4 Cardiac Rhythm Management Devices Market, China, Distribution Share by Revenue ($m), 2023
3.5 Cardiac Rhythm Management Devices Market, China, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in China, Cardiac Rhythm Management Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Boston Scientific Corp
4.3.1 Company Overview
4.4 MicroPort Scientific Corp
4.4.1 Company Overview
4.5 Biotronik SE & Co KG
4.5.1 Company Overview
5 Cardiac Rhythm Management Devices Market Pipeline Products6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 MicroPort Scientific to Raise USD220 Million in Public Offering of 5.75% Convertible Bonds Due 2028
6.2 Venture Financing
6.2.1 Shenyang Shenda Endoscope Raises Funds through Series C Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 Nov 20, 2023: Concord Medical Schedules 2023 Annual Meeting of Shareholders
7.1.2 Nov 10, 2023: Microport Appointment of Director
7.2 Financial Announcements
7.2.1 May 13, 2024: Stereotaxis Reports 2024 First Quarter Financial Results
7.2.2 Sep 22, 2023: Concord Medical Reports Financial Results for the First Half of 2023
7.2.3 Sep 21, 2023: Microport Scientific Corp. Announces 2023 Interim Report
7.3 Strategy And Business Planning
7.3.1 Jun 20, 2023: Shenzhen Mindray Bio-Medical Electronics Receives an Additional 510(k) Clearance for M11 Diagnostic Ultrasound System
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Cardiac Rhythm Management Devices Market, China, Revenue ($m), USD Constant, 2018-2033
Table 2: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), USD Constant, 2018-2033
Table 3: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), USD Constant, 2018-2033
Table 4: Pacemakers Market, China, Revenue ($m), USD Constant, 2018-2033
Table 5: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2018-2033
Table 6: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2018-2033
Table 7: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2018-2033
Table 8: Pacemakers Market, China, Volume (Units), 2018-2033
Table 9: Cardiac Rhythm Management Devices Market, China, Average Price ($), 2018-2033
Table 10: Cardiac Rhythm Management Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2023
Table 11: Cardiac Rhythm Management Devices Market, China, Company Share by Revenue ($m), USD Constant, 2023
Table 12: Cardiac Rhythm Management Devices Market Pipeline Products
Table 13: MicroPort Scientific to Raise USD220 Million in Public Offering of 5.75% Convertible Bonds Due 2028
Table 14: Shenyang Shenda Endoscope Raises Funds through Series C Financing
Table 15: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Cardiac Rhythm Management Devices Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 4: Pacemakers Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 5: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2018-2033
Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2018-2033
Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2018-2033
Figure 8: Pacemakers Market, China, Volume (Units), 2018-2033
Figure 9: Cardiac Rhythm Management Devices Market, China, Company Share (%) 2023